|
US7902121B2
(en)
*
|
2001-07-02 |
2011-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
MHC-antigen arrays for detection and characterization of immune responses
|
|
US20070196346A1
(en)
*
|
2003-08-21 |
2007-08-23 |
Brown Michael P |
Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer
|
|
WO2005033278A2
(en)
*
|
2003-09-30 |
2005-04-14 |
Ludwig Institute For Cancer Research |
In vivo efficacy of ny-eso-1 plus iscom
|
|
CU23297A1
(es)
*
|
2004-11-16 |
2008-07-24 |
Ct De Inmunologa A Molecular |
Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer
|
|
WO2006122050A2
(en)
|
2005-05-05 |
2006-11-16 |
The Government Of The United States Of America, As Represented By The Secretary |
Methods and compositions for detecting immune responses
|
|
DK1989224T3
(da)
|
2006-02-24 |
2011-02-14 |
Us Gov Health & Human Serv |
Immunogene peptider og anvendelsesmetoder
|
|
US20080095790A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Perambakam Supriya M |
Methods of Treating Prostate Cancer
|
|
CN100522460C
(zh)
*
|
2007-12-15 |
2009-08-05 |
江西江铃底盘股份有限公司 |
一种桥壳总成的焊接夹具及焊接工艺
|
|
JP2013504599A
(ja)
*
|
2009-09-14 |
2013-02-07 |
ベイラー リサーチ インスティテュート |
ランゲルハンス細胞に向けられたワクチン
|
|
WO2012006634A2
(en)
*
|
2010-07-09 |
2012-01-12 |
The Board Of Trustees Of The University Of Illiniois |
Prostate specific antigen (psa) peptide therapy
|
|
US8557777B2
(en)
|
2010-07-09 |
2013-10-15 |
The Board Of Trustees Of The University Of Illinois |
Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
|
|
US20120263754A1
(en)
|
2011-02-15 |
2012-10-18 |
Immune Design Corp. |
Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
|
|
WO2012141984A1
(en)
|
2011-04-08 |
2012-10-18 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
WO2013019445A2
(en)
|
2011-07-29 |
2013-02-07 |
Health Research, Inc. |
Anti-angiogenic peptides and uses thereof
|
|
JP6312141B2
(ja)
|
2012-03-30 |
2018-04-18 |
国立大学法人京都大学 |
前立腺がん検査用尿中バイオマーカー
|
|
KR102136433B1
(ko)
|
2012-05-16 |
2020-07-22 |
이뮨 디자인 코포레이션 |
Hsv-2 백신
|
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
|
CA2939093A1
(en)
|
2014-02-14 |
2015-08-20 |
Immune Design Corp. |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
|
JP2017515841A
(ja)
|
2014-05-13 |
2017-06-15 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
腫瘍抗原を発現するポックスウイルス及びｔｉｍ−３に対するモノクローナル抗体を用いた癌治療のための併用療法
|
|
EP3169352A1
(en)
|
2014-07-15 |
2017-05-24 |
Immune Design Corp. |
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
|
|
US20190183870A1
(en)
|
2016-01-05 |
2019-06-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Combination of histone deacetylase inhibitor and immunotherapy
|
|
WO2017136342A1
(en)
|
2016-02-02 |
2017-08-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fulvestrant for inducing immune-mediated cytotoxic lysis of cancer cells
|
|
EP4706777A2
(en)
|
2016-04-15 |
2026-03-11 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
IL262365B2
(en)
|
2016-04-15 |
2024-11-01 |
Alpine Immune Sciences Inc |
Immunomodulatory proteins ICOS ligand variants and uses thereof
|
|
US11834490B2
(en)
|
2016-07-28 |
2023-12-05 |
Alpine Immune Sciences, Inc. |
CD112 variant immunomodulatory proteins and uses thereof
|
|
CN110088127A
(zh)
|
2016-07-28 |
2019-08-02 |
高山免疫科学股份有限公司 |
Cd155变体免疫调节蛋白及其用途
|
|
US11471488B2
(en)
|
2016-07-28 |
2022-10-18 |
Alpine Immune Sciences, Inc. |
CD155 variant immunomodulatory proteins and uses thereof
|
|
PT3596116T
(pt)
|
2017-03-16 |
2023-12-04 |
Alpine Immune Sciences Inc |
Proteínas imunomoduladoras de pd-l1 variante e suas utilizações
|
|
EP3596114A2
(en)
|
2017-03-16 |
2020-01-22 |
Alpine Immune Sciences, Inc. |
Cd80 variant immunomodulatory proteins and uses thereof
|
|
JP2020511144A
(ja)
|
2017-03-16 |
2020-04-16 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
Ｐｄ−ｌ２バリアント免疫調節タンパク質及びその使用
|
|
MX2019011599A
(es)
|
2017-03-30 |
2019-12-19 |
Univ Queensland |
Moleculas quimericas y usos de las mismas.
|
|
KR102754876B1
(ko)
|
2017-08-24 |
2025-01-13 |
버베리안 노딕 에이/에스 |
재조합 mva 및 항체의 정맥내 투여에 의한 암 치료를 위한 병용 요법
|
|
WO2019040994A1
(en)
|
2017-09-01 |
2019-03-07 |
The Australian National University |
IMMUNOREGULATOR MOLECULES AND USES THEREOF
|
|
KR102813968B1
(ko)
|
2017-10-10 |
2025-05-29 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
Ctla-4 변이체 면역조절 단백질 및 이의 용도
|
|
SMT202600062T1
(it)
|
2017-10-18 |
2026-03-09 |
Alpine Immune Sciences Inc |
Proteine immunomodulatrici del ligando di icos variante e composizioni e metodi correlati
|
|
SG11202006148UA
(en)
|
2018-01-03 |
2020-07-29 |
Alpine Immune Sciences Inc |
Multi-domain immunomodulatory proteins and methods of use thereof
|
|
US12065476B2
(en)
|
2018-06-15 |
2024-08-20 |
Alpine Immune Sciences, Inc. |
PD-1 variant immunomodulatory proteins and uses thereof
|
|
AU2019345151B2
(en)
|
2018-09-19 |
2025-04-17 |
Alpine Immune Sciences, Inc. |
Methods and uses of variant CD80 fusion proteins and related constructs
|
|
JP7555334B2
(ja)
|
2018-10-05 |
2024-09-24 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
組み換えｍｖａ、及び免疫チェックポイントアンタゴニストまたは免疫チェックポイントアゴニストの静脈内投与によって、がんを治療する併用療法
|
|
MX2021005560A
(es)
|
2018-11-20 |
2021-06-23 |
Bavarian Nordic As |
Terapia para el tratamiento del cancer con administracion intratumoral y/o intravenosa de un virus vaccinia ankara (mva) recombinante que codifica ligando 4-1bbl (cd137l) y/o ligando del cumulo o grupo de diferenciacion 40 (cd40l).
|
|
WO2020113141A2
(en)
|
2018-11-30 |
2020-06-04 |
Alpine Immune Sciences, Inc. |
Cd86 variant immunomodulatory proteins and uses thereof
|
|
EP4438054A3
(en)
|
2019-04-17 |
2025-01-08 |
Alpine Immune Sciences, Inc. |
Methods and uses of variant icos ligand (icosl) fusion proteins
|
|
CN114867491B
(zh)
|
2019-11-20 |
2025-08-15 |
巴法里安诺迪克有限公司 |
用于肿瘤内和/或静脉内施用以治疗癌症的重组mva病毒
|
|
JP7748393B2
(ja)
|
2020-05-08 |
2025-10-02 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
Ａｐｒｉｌおよびｂａｆｆ阻害免疫調節タンパク質、ならびにその使用方法
|
|
KR20240019124A
(ko)
|
2021-05-07 |
2024-02-14 |
알파인 이뮨 사이언시즈, 인코포레이티드 |
Taci-fc 융합 면역조절 단백질의 투여 및 치료 방법
|
|
EP4452305A1
(en)
|
2021-12-23 |
2024-10-30 |
Bavarian Nordic A/S |
Recombinant mva viruses for intraperitoneal administration for treating cancer
|
|
WO2023172883A1
(en)
|
2022-03-07 |
2023-09-14 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
|
|
WO2024077018A2
(en)
|
2022-10-04 |
2024-04-11 |
Alpine Immune Sciences, Inc. |
Methods and uses of taci-fc fusion immunomodulatory protein
|